C
TEVA icon

Covestor’s Teva Pharmaceuticals TEVA Stock Holding History

Covestor’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Sell
3,696
-26
-0.7% -$866 0.07% 262
2026
Q1 		$112K Hold
3,722
– – 0.08% 249
2025
Q4 		$116K Hold
3,722
– – 0.06% 496
2025
Q3 		$75K Hold
3,722
– – 0.04% 719
2025
Q2 		$62K Buy
3,722
+1,851
+99% +$29.9K 0.04% 801
2025
Q1 		$29K Buy
1,871
+999
+115% +$17.8K 0.02% 1063
2024
Q4 		$19K Buy
+872
New +$15.9K 0.01% 1229
2024
Q3 		– Sell
-6,501
Closed -$106K – 2757
2024
Q2 		$106K Hold
6,501
– – 0.07% 450
2024
Q1 		$92K Buy
6,501
+101
+2% +$1.27K 0.06% 598
2023
Q4 		$67K Buy
+6,400
New +$59.8K 0.05% 724
2022
Q1 		– Sell
-2,803
Closed -$22K – 2440
2021
Q4 		$22K Buy
+2,803
New +$25.3K 0.03% 841

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Covestor's TEVA Position: Q2 2026 in Review

Covestor reduced its Teva Pharmaceuticals (TEVA) stake by 0.7% in Q2 2026, selling an estimated $866 and leaving 3,696 shares worth $125K. The position accounts for 0.07% of the portfolio, ranked #262.

Covestor first reported a position in TEVA in Q4 2021 and has held it in 11 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Covestor held 3,696 shares of Teva Pharmaceuticals worth $125K as of Q2 2026.
  • Covestor sold 26 Teva Pharmaceuticals shares in Q2 2026, an estimated $866.
  • Teva Pharmaceuticals made up 0.07% of Covestor's portfolio in Q2 2026, its #262 holding.
  • Covestor first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.